Saltar al contenido
Merck
Buscar dentro

200-066-2

Filtros aplicados
Palabra clave:'200-066-2'
Mostrando 1-1 of 1 resultado para "200-066-2" en el plazo de Papeles
Craig W Hendrix et al.
AIDS research and human retroviruses, 32(1), 32-43 (2015-09-29)
Oral preexposure prophylaxis (PrEP) trials report disparate efficacy attributed to variable adherence. HPTN 066 was conducted to establish objective, quantitative benchmarks for discrete, regular levels of adherence using directly observed dosing of tenofovir (TFV) disoproxil fumarate (TDF)/emtricitabine (FTC). Healthy, HIV-uninfected
Página 1 de 1